UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.807

Sortiert nach

The clinical use of structural MRI in Alzheimer disease

Nature reviews. Neurology, 2010-02, Vol.6 (2), p.67

2010

Link zum Volltext

Verfügbarkeit prüfen

Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play

Radiology, 2012-05, Vol.263 (2), p.344

Jack, Jr, Clifford R

2012

Link zum Volltext

Verfügbarkeit prüfen

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

Lancet neurology, 2013-02, Vol.12 (2), p.207-216

2013

Link zum Volltext

Verfügbarkeit prüfen

Testing the right target and right drug at the right stage

Science translational medicine, 2011-11, Vol.3 (111), p.111cm33

2011

Link zum Volltext

Verfügbarkeit prüfen

Non-stationarity in the "resting brain's" modular architecture

PloS one, 2012-06, Vol.7 (6), p.e39731-e39731

2012

Link zum Volltext

Verfügbarkeit prüfen

Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials

Alzheimer's & dementia, 2017-04, Vol.13 (4), p.e1-e85

2017

Link zum Volltext

Verfügbarkeit prüfen

Decreased brain stiffness in Alzheimer's disease determined by magnetic resonance elastography

Journal of magnetic resonance imaging, 2011-09, Vol.34 (3), p.494-498

2011

Link zum Volltext

Verfügbarkeit prüfen

Suspected non-Alzheimer disease pathophysiology--concept and controversy

Nature reviews. Neurology, 2016-02, Vol.12 (2), p.117

2016

Link zum Volltext

Verfügbarkeit prüfen

Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study

Lancet neurology, 2012-10, Vol.11 (10), p.868-877

2012

Link zum Volltext

Verfügbarkeit prüfen

Defining imaging biomarker cut points for brain aging and Alzheimer's disease

Alzheimer's & dementia, 2017-03, Vol.13 (3), p.205-216

2017

Link zum Volltext

Verfügbarkeit prüfen

Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50–95 years: a cross-sectional study

Lancet neurology, 2017-06, Vol.16 (6), p.435-444

2017

Link zum Volltext

Verfügbarkeit prüfen

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Lancet neurology, 2010, Vol.9 (1), p.119-128

2010

Link zum Volltext

Verfügbarkeit prüfen

The transformative potential of plasma phosphorylated tau

Lancet neurology, 2020-05, Vol.19 (5), p.373-374

Jack, Clifford R

2020

Link zum Volltext

Verfügbarkeit prüfen

Criteria for a biological definition of neuronal α-synuclein disease—a major conceptual step forward

Lancet neurology, 2024-02, Vol.23 (2), p.129-130

Jack, Clifford R

2024

Link zum Volltext

Verfügbarkeit prüfen

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Alzheimer's & dementia, 2011-05, Vol.7 (3), p.257-262

2011

Link zum Volltext

Verfügbarkeit prüfen

The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement

Alzheimer's & dementia, 2017-05, Vol.13 (5), p.561-571

2017

Link zum Volltext

Verfügbarkeit prüfen

Preclinical Alzheimer's disease: a valid concept

Lancet neurology, 2020-01, Vol.19 (1), p.31-31

Jack, Clifford R

2020

Link zum Volltext

Verfügbarkeit prüfen

A Bayesian Approach to Multistate Hidden Markov Models: Application to Dementia Progression

Journal of the American Statistical Association, 2020-01, Vol.115 (529), p.16-31

2020

Link zum Volltext

Verfügbarkeit prüfen

Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study

Lancet neurology, 2014-10, Vol.13 (10), p.997-1005

2014

Link zum Volltext

Verfügbarkeit prüfen

A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity

NeuroImage clinical, 2016-01, Vol.11 (C), p.802-812

2016

Link zum Volltext

Verfügbarkeit prüfen

Diabetes, Prediabetes, and Brain Volumes and Subclinical Cerebrovascular Disease on MRI: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS)

Diabetes care, 2017-11, Vol.40 (11), p.1514-1521

2017

Link zum Volltext

Verfügbarkeit prüfen

Performance of plasma phosphorylated tau 181 and 217 in the community

Nature medicine, 2022-07, Vol.28 (7), p.1398-1405

2022

Link zum Volltext

Verfügbarkeit prüfen

[18F]AV‐1451 tau positron emission tomography in progressive supranuclear palsy

Movement disorders, 2017-01, Vol.32 (1), p.124-133

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.807

Suche als RSS-Feed

Aktive Filter

ThemaNeurosciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.736)
Mit Volltextzugriff
(1.568)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.807)
Japanisch
(188)
Norwegisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The clinical use of structural MRI in Alzheimer disease

Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

Testing the right target and right drug at the right stage

Non-stationarity in the "resting brain's" modular architecture

Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials

Decreased brain stiffness in Alzheimer's disease determined by magnetic resonance elastography

Suspected non-Alzheimer disease pathophysiology--concept and controversy

Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study

Defining imaging biomarker cut points for brain aging and Alzheimer's disease

Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50–95 years: a cross-sectional study

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

The transformative potential of plasma phosphorylated tau

Criteria for a biological definition of neuronal α-synuclein disease—a major conceptual step forward

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement

Preclinical Alzheimer's disease: a valid concept

A Bayesian Approach to Multistate Hidden Markov Models: Application to Dementia Progression

Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study

A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

Diabetes, Prediabetes, and Brain Volumes and Subclinical Cerebrovascular Disease on MRI: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS)

Performance of plasma phosphorylated tau 181 and 217 in the community

[18F]AV‐1451 tau positron emission tomography in progressive supranuclear palsy

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Aktive Filter

Suchergebnisse filtern